The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer
|
|
- Albert Newman
- 5 years ago
- Views:
Transcription
1 The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer MRC Clinician Scientist Honorary Consultant Neurologist Dementia Research Centre, UCL Institute of Neurology National Hospital for Neurology and Neurosurgery
2 Outline of the talk: 10 things to know about FTD 1. FTD is more common than you might think 2. Research in FTD is increasing 3. FTD is not just one disease clinically 4. The most common form presents with behavioural symptoms but the language form is also seen frequently 5. FTD is not just one disease pathologically 6. FTD is commonly genetic 7. MR imaging is variable but can be helpful diagnostically 8. Other tests are less useful 9. Therapeutic drug trials are now starting 10. Support is available for these rare diseases
3 History First case was described by Arnold Pick in 1892 Non-AD inclusions (later known as Pick bodies) described by Alois Alzheimer in 1911 Concept of Pick s disease described later in 1925/1926 by Gans/Onari and Spatz Sparse case reports until 1980 s when resurgence of interest, although first diagnostic criteria ( frontotemporal dementia ) only described in 1994
4 1. FTD is more common than you think
5 Epidemiology Second most common young onset degenerative dementia almost as common as AD. Recent large epidemiological study (Coyle-Gilchrist et al, 2016) Prevalence: 10.8/100,000 Incidence: 1.6/100,000 person years Estimated lifetime risk: 1 in 742 Age-adjusted prevalence peaks between at 42.6/100,000 Prevalence for people >65 is double that of 40-64
6 2. Research in FTD is increasing
7 Increasing interest in FTD over the years Number of papers on FTD in Pubmed
8 3. FTD is not just one disease clinically
9 Clinical spectrum of FTD Frontotemporal dementia Behavioural Language Behavioural variant frontotemporal dementia (bvftd) Progressive nonfluent aphasia (PNFA) Semantic dementia (SD) Primary progressive aphasia (PPA)
10 Overlap with other conditions Atypical parkinsonian syndromes: Progressive supranuclear palsy (bvftd, PNFA) Corticobasal (degeneration) syndrome (bvftd, PNFA) Motor neurone disease/amyotrophic lateral sclerosis (bvftd >> PNFA and rare descriptions of SD)
11 4. The most common form presents with behavioural symptoms but the language form is also seen frequently
12 Consensus criteria Lund-Manchester criteria 1994 Neary criteria 1998 McKhann criteria 2001 Mesulam PPA criteria 1998/2001 New criteria: Rascovsky International bvftd Consortium criteria for bvftd Brain 2011
13 Behavioural variant FTD new criteria 1. Disinhibition Socially inappropriate behaviour Loss of manners or decorum Impulsive, rash or careless actions 2. Apathy/inertia 3. Loss of sympathy/empathy 4. Perseverative, stereotyped and compulsive behaviour Simple repetitive movements Complex, compulsive or ritualistic behaviours 5. Hyperorality/dietary changes Altered food preference sweet tooth, binge eating 6. Executive dysfunction
14 PPA subtypes New classification published in Neurology March (rather than 2) subtypes: SD PNFA LPA = logopenic aphasia (first described 2004)
15 Semantic dementia Multimodal loss of semantic knowledge: verbal initially then visual, auditory, olfactory, gustatory Fluent speech with semantic errors Anomia Single word comprehension problems Surface dyslexia Later, nonverbal impairment e.g. visual agnosia
16 Splitting the progressive aphasias Traditionally 2 subtypes SD = fluent aphasia PNFA = nonfluent aphasia Problem: PNFA very mixed Agrammatism Motor speech impairment: apraxia of speech Anomia Word-finding pauses New classification splits nonfluent patients into PNFA (more anterior tau > TDP-43 path) and LPA (more posterior AD path)
17 5. FTD is not just one disease pathologically
18 Pathological subtypes Frontotemporal lobar degeneration (FTLD) Tau-positive Ubiquitin-positive, tau-negative (FTLD-U) 4R 4R +/- 3R 3R FTLD-TDP FTLD-FUS FTLD-UPS 1. CBD 2. PSP 3. AGD 5. MAPT mutations 6. NTD 6. Pick s disease 7. Type A 8. Type B 9. Type C 12. aftldu 13. NIFID 14. BIBD 15. CHMP2B mutations 4. GGT 10. Type D 11. Other AD pathology:?10-20% of bvftd; PPA (LPA most and?<5% of SD and PNFA)
19 Tau CBD Atypical parkinsonism MAPT PSP PICK S MAPT CBS PSPS GRN TDP-43 A bvftd C9ORF72 B C D PPA PNFA FUS aftldu SD VCP NIFID BIBD FTD- ALS
20 6. FTD is commonly genetic
21 Genetics of FTD Up to 50% of patients with FTD describe a family history of a dementia But a smaller number have an autosomal dominant inheritance (~a third) And variable across clinical syndromes
22 Genetics of FTD Which are the genes involved in FTD? 1998 Microtubule-associated protein tau (MAPT) 2004 Valosin-containing protein (VCP) 2005 Charged multivesicular body protein 2B (CHMP2B) 2006 Progranulin (GRN) 2008 TAR-DNA binding protein (TARDP) 2009 Fused-in-sarcoma (FUS) 2011 Chromosome 9 open reading frame 72 (C9orf72) Sequestosome 1 (SQSTM1)
23 Genetics of FTD Which are the genes involved in FTD? 1998 Microtubule-associated protein tau (MAPT) 2004 Valosin-containing protein (VCP) 2005 Charged multivesicular body protein 2B (CHMP2B) 2006 Progranulin (GRN) 2008 TAR-DNA binding protein (TARDP) 2009 Fused-in-sarcoma (FUS) 2011 Chromosome 9 open reading frame 72 (C9orf72) Sequestosome 1 (SQSTM1)
24 When and what to test? On family history Autosomal dominant family history commonly present but not always On clinical syndrome: bvftd: any of the genes (C9orf72 if delusions) FTD-MND: C9orf72 PNFA: GRN >>C9orf72 CBS: MAPT > GRN PSP syndrome: rare cases of MAPT mutations
25 Risk of genetic mutation bvftd autosomal dominant family history: chance of finding a known mutation is ~90% with a single young onset (<65) first degree relative: risk is ~60% with a single older onset (>65) first degree relative: risk is ~25% no known family history: risk is ~10% PPA: risk is <5% This is mostly in patients with PNFA SD: risk is <1% (0 in UCL cohort) CBS: risk is 1% PSP: risk is <0.5%
26 When and what to test? Next generation sequencing will allow us to test all the genes at the same time (apart from C9orf72). But multiple variants in same person what s pathogenic? Some people carry double mutations e.g. in C9orf72 and GRN
27 7. MR imaging is variable but can be helpful diagnostically
28 Behavioural variant FTD 1. T > P/F 3. F > T 2. Mainly T 4. Mainly F Temporal-predominant Frontal-predominant
29 Behavioural variant FTD - phenocopy
30 Semantic dementia Early Middle Late
31 Semantic dementia Early Middle Late
32 Semantic dementia Early Middle Late
33 Early Progressive nonfluent aphasia
34 Progressive nonfluent aphasia Early Middle
35 Progressive nonfluent aphasia Early Middle Late
36 8. Other tests are less useful
37 How useful is CSF? Exclude AD pathology NB: raised tau NOT a marker of tau pathology PET scan? FDG-PET or SPECT no large advantage over volumetric MRI; less knowledge about variability in different subtypes Amyloid (AV45/Florbetapir) will become available to help exclude AD pathology in very specific circumstances Tau (e.g. AV1451) experimental and unlikely to be available soon DaTscan? Probably not
38 9. Therapeutic trials are now starting
39 Current and forthcoming trials in FTD TauRx: methylene blue Forum: HDAC inhibitor for GRN mutations Multiple tau trials (monoclonal antibodies, ASO, others ) for MAPT mutations/psp ASO trial for C9orf72
40 10. Support is available for these rare diseases
41
42
43 Summary and the future FTD still a clinical diagnosis supported by neuroimaging Poor clinico-pathological correlation Genetic testing worth doing in certain circumstances Therapeutic trials now starting Patients and family members benefit from disease-specific support groups
44 Outline of the talk: 10 things to know about FTD 1. FTD is more common than you might think 2. Research in FTD is increasing 3. FTD is not just one disease clinically 4. The most common form presents with behavioural symptoms but the language form is also seen frequently 5. FTD is not just one disease pathologically 6. FTD is commonly genetic 7. MR imaging is variable but can be helpful diagnostically 8. Other tests are less useful 9. Therapeutic drug trials are now starting 10. Support is available for these rare diseases
45 Acknowledgements Patients and their families Dementia Research Centre Nick Fox Jason Warren Jonathan Schott Martin Rossor Cath Mummery Funding MRC NIHR ARUK Alzheimer s Society
Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia
Perspectives on Frontotemporal Dementia and Primary Progressive Aphasia Bradley F. Boeve, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Alzheimer s Disease
More informationFrontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.
I.1 I.2 II.1 II.2 II.3 II.4 II.5 II.6 III.1 III.2 III.3 III.4 III.5 III.6 III.7 III.8 III.9 III.10 III.11 III.12 IV.1 IV.2 IV.3 IV.4 IV.5 Frontotemporal Dementia: Towards better diagnosis Frontotemporal
More informationFRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS
FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS Norman L. Foster, M.D. Director, Center for Alzheimer s Care, Imaging and Research Chief, Division of Cognitive Neurology, Department of Neurology
More informationFTD basics! Etienne de Villers-Sidani, MD!
FTD basics! Etienne de Villers-Sidani, MD! Frontotemporal lobar degeneration (FTLD) comprises 3 clinical syndromes! Frontotemporal dementia (behavioral variant FTD)! Semantic dementia (temporal variant
More informationDementia Update. Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota
Dementia Update Daniel Drubach, M.D. Division of Behavioral Neurology Department of Neurology Mayo Clinic Rochester, Minnesota Nothing to disclose Dementia Progressive deterioration in mental function
More informationI do not have any disclosures
Alzheimer s Disease: Update on Research, Treatment & Care Clinicopathological Classifications of FTD and Related Disorders Keith A. Josephs, MST, MD, MS Associate Professor & Consultant of Neurology Mayo
More informationForm D1: Clinician Diagnosis
Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.
More informationObjectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1
Frontotemporal Degeneration and Primary Progressive Aphasia Caregiver and Professional Education Conference Diana R. Kerwin, MD Assistant Professor of Medicine-Geriatrics Cognitive Neurology and Alzheimer
More information! slow, progressive, permanent loss of neurologic function.
UBC ! slow, progressive, permanent loss of neurologic function.! cause unknown.! sporadic, familial or inherited.! degeneration of specific brain region! clinical syndrome.! pathology: abnormal accumulation
More informationLANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION
LANGUAGE AND PATHOLOGY IN FRONTOTEMPORAL DEGENERATION Murray Grossman University of Pennsylvania Support from NIH (AG17586, AG15116, NS44266, NS35867, AG32953, AG38490), IARPA, ALS Association, and the
More informationObjectives. RAIN Difficult Diagnosis 2014: A 75 year old woman with falls. Case History: First visit. Case History: First Visit
Objectives RAIN Difficult Diagnosis 2014: A 75 year old woman with falls Alexandra Nelson MD, PhD UCSF Memory and Aging Center/Gladstone Institute of Neurological Disease Recognize important clinical features
More informationSandra Weintraub, PhD Clinical Core Leader and Professor
Sandra Weintraub, PhD Clinical Core Leader and Professor Northwestern Cognitive Neurology and Alzheimer s Disease Center (CNADC) Chicago, Illinois www.brain.northwestern.edu Why is it so difficult to diagnose
More informationFrontotemporal dementia:
Frontotemporal dementia: Where we ve been What s on the horizon Howard Rosen, M.D. UCSF Department of Neurology Memory and Aging Center www.memory.ucsf.edu None Disclosures Overview FTD, What is it? Origins
More informationdoi: /brain/awr198 Brain 2011: 134;
doi:10.1093/brain/awr198 Brain 2011: 134; 2565 2581 2565 BRAIN A JOURNAL OF NEUROLOGY Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration Jonathan D. Rohrer,
More informationClinical Genetics & Dementia
Clinical Genetics & Dementia Dr Nayana Lahiri Consultant in Clinical Genetics & Honorary Senior Lecturer Nayana.lahiri@nhs.net Aims of the Session To appreciate the potential utility of family history
More informationDementia Past, Present and Future
Dementia Past, Present and Future Morris Freedman MD, FRCPC Division of Neurology Baycrest and University of Toronto Rotman Research Institute, Baycrest CNSF 2015 Objectives By the end of this presentation,
More informationRuolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce
Ruolo dei biomarcatori come criterio di supporto nella diagnostica delle demenze ad esordio precoce ALESSANDRO MARTORANA UOC NEUROLOGIA-CENTRO ALZHEIMER POLICLINICO TOR VERGATA-UNIVERSITÀ DI ROMA TOR VERGATA
More informationDEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD
DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD OBJECTIVES Terminology/Dementia Basics Most Common Types Defining features Neuro-anatomical/pathological underpinnings Neuro-cognitive
More informationFTD: Improving Outcomes & Outreach
2nd Annual Frontotemporal Degeneration Caregiver Education Conference Raleigh, NC 7.25.12 FTD: Improving Outcomes & Outreach Dan Kaufer, MD Associate Professor, Neurology Director, Memory Disorders Program
More informationNCRAD. Single Gene Implicated in FTD/ALS UCSF Memory and Aging Center, San Francisco, California
The National Cell Repository for Alzheimer s Disease (NCRAD) is a data and specimen collection source for families with Alzheimer disease (AD) or serious memory loss. Families having two or more living
More informationAGING, DEMENTIA, COGNITIVE AND BEHAVIOURAL NEUROLOGY
AGING, DEMENTIA, COGNITIVE AND BEHAVIOURAL NEUROLOGY Professor Tim Lynch Dublin Neurological Institute at the Mater Misericordiae University Hospital University College Dublin Dublin, IRELAND This Case-based
More informationForm A3: Subject Family History
Initial Visit Packet NACC Uniform Data Set (UDS) Form A: Subject Family History ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by a clinician
More informationDo not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009
Sandra Weintraub, Ph.D. Clinical Core Director, Cognitive Neurology and Alzheimer s Disease Center Northwestern University Feinberg School of Medicine Chicago, Illinois Dementia: a condition caused by
More informationWhite matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration
White matter hyperintensities correlate with neuropsychiatric manifestations of Alzheimer s disease and frontotemporal lobar degeneration Annual Scientific Meeting Canadian Geriatric Society Philippe Desmarais,
More informationThe genetics and neuropathology of frontotemporal lobar degeneration
Acta Neuropathol (2012) 124:353 372 DOI 10.1007/s00401-012-1029-x REVIEW The genetics and neuropathology of frontotemporal lobar degeneration Anne Sieben Tim Van Langenhove Sebastiaan Engelborghs Jean-Jacques
More information3/7/2017. Alzheimer s and Dementia Research: An Advanced Discussion. Alzheimer s and Dementia Research: An Advanced Discussion
Alzheimer s and Dementia Research: An Advanced Discussion Brad Boeve, MD Department of Neurology Mayo Clinic Alzheimer s and Dementia Research: An Advanced Discussion Theoretical Constructs in Aging/Dementia
More informationWhat is. frontotemporal. address? dementia?
What is frontotemporal address? dementia? Contents 03 What is frontotemporal dementia? 04 Symptoms 05 Diagnosis 06 Treatments Information in this booklet is for anyone who wants to know more about frontotemporal
More informationFRONTO TEMPORAL DEMENTIA
FRONTO TEMPORAL DEMENTIA Dr. Diana Paleacu Kertesz Neurology Service and Memory Clinic Abarbanel Mental Health Center Department of Neurology, Tel Aviv University DAT: 55-60% VD: 15-20% DLBD: 15-20% FTD:
More informationFRONTO TEMPORAL DEMENTIA
FRONTO TEMPORAL DEMENTIA Dr. Diana Paleacu Kertesz Neurology Service and Memory Clinic Abarbanel Mental Health Center Department of Neurology, Tel Aviv University Fronto-Temporal Lobe Dementia (FTLD) DAT:
More informationConfronting the Clinical Challenges of Frontotemporal Dementia
Confronting the Clinical Challenges of Frontotemporal Dementia A look at FTD s symptoms, pathophysiology, subtypes, as well as the latest from imaging studies. By Zac Haughn, Senior Associate Editor Ask
More informationWhat is frontotemporal dementia?
What is frontotemporal dementia? Introduction Information in this introductory booklet is for anyone who wants to know more about frontotemporal dementia (FTD). This includes people living with FTD, their
More informationOverview of the non-alzheimer Dementias
Overview of the non-alzheimer Dementias Chiadi U. Onyike, MD, MHS FTD/Young-Onset Dementias Program Johns Hopkins Neuropsychiatry Disclaimer Dr. Onyike is a principal investigator for the Baltimore site
More informationBiomarkers: Translating Research into Clinical Practice
Biomarkers: Translating Research into Clinical Practice AFTD Education Conference San Diego, April 2015 Nadine Tatton, PhD Scientific Director, AFTD HelpLine 866-5507-7222 u info@theaftd.org u www.theaftd.org
More informationFrontotemporal Dementia
Frontotemporal Dementia clinical, genetic, and pathological heterogeneity Harro Seelaar The studies in this thesis were funded by: Stichting Dioraphte Hersenstichting Nederland Prinses Beatrix Fonds Nuts
More informationFrontotemporal Degeneration
#96100 Frontotemporal Degeneration COURSE #96100 2 CONTACT/CLOCK HOURS Release Date: 11/01/15 Expiration Date: 10/31/18 Frontotemporal Degeneration HOW TO RECEIVE CREDIT Read the enclosed course. Complete
More informationRole of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases
Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer
More informationProf Tim Anderson. Neurologist University of Otago Christchurch
Prof Tim Anderson Neurologist University of Otago Christchurch Tim Anderson Christchurch Insidious cognitive loss From subjective memory complaints (SMC) to dementia Case 1. AR. 64 yrs Male GP referral
More informationFrontotemporal dementia Recent advances
Frontotemporal dementia Recent advances Dr Jonathan Rohrer MRC Clinician Scientist Honorary Consultant Neurologist The problem of UCL Institute of Neurology National Hospital for Neurology and Neurosurgery
More informationFrontotemporal Degeneration
#66100 Frontotemporal Degeneration COURSE #66100 2 CE CREDITS Release Date: 11/01/15 Expiration Date: 10/31/18 Frontotemporal Degeneration Faculty Ellen Steinbart, RN, MA, received a Bachelor of Arts from
More informationBiochimica et Biophysica Acta
Biochimica et Biophysica Acta 1822 (2012) 325 332 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbadis Review Structural brain imaging
More informationPhenotypic Variability in ALS
Phenotypic Variability in ALS Michael A. Elliott, MD, FAAN Medical Director, ALS Clinic Swedish Neuroscience Institute 1 Outline ALS Background Description Typical Presentation Clinical Phenotype Motor
More informationDementia Update. October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada
Dementia Update October 1, 2013 Dylan Wint, M.D. Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, Nevada Outline New concepts in Alzheimer disease Biomarkers and in vivo diagnosis Future trends
More information2016 Programs & Information
Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia
More informationgenetics 101 FTD/PPA Family Caregiver and Professional Education and Support Conference 2012
agenda genetic counseling genetics 101 genetics of FTD and PPA Lisa Kinsley, MS, CGC, genetic counselor HyungSub Shim, MD, neurology fellow, CNADC how does my fit in? what to expect what is a genetic counselor?
More informationWhat is frontotemporal dementia (FTD)?
What is frontotemporal dementia (FTD)? Factsheet 404LP April 2016 Frontotemporal dementia (FTD) is one of the less common types of dementia. The term covers a wide range of different conditions. It is
More informationCerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
Woollacott et al. Alzheimer's Research & Therapy (2018) 10:79 https://doi.org/10.1186/s13195-018-0405-8 RESEARCH Open Access Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by
More informationPaper Title Theme Presentation Type Poster Presentatio n Day
A NOVEL PROBE OF FUNCTIONAL NETWORK ARCHITECTURE IN PROTEINOPATHIES: SPECTRAL DCM IN SEMANTIC DEMENTIA Blood and imaging biomarkers Poster and Data Blitz Monday 1 M1 PATHWAYS PREDICTION & RISK-GENE PRIORITIZATION
More informationClinical, genetic and pathological heterogeneity of frontotemporal dementia: a review
1 Department of Neurology, Erasmus MCdUniversity Medical Centre Rotterdam, Rotterdam, The Netherlands 2 Dementia Research Centre, UCL Institute of Neurology, London, UK 3 Department of Neurology, VU University
More informationFTD/PPA Caregiver Education Conference March 11, 2011
FTD/PPA Caregiver Education Conference March 11, 2011 Question and Answer Session Answered by Joseph Cooper, MD, Darby Morhardt, MSW, LCSW, Mary O Hara, AM, LCSW, Jaimie Robinson, MSW, LCSW, Emily Rogalski,
More informationIntroduction. Overview
Frontotemporal dementia Marissa C Natelson Love MD ( Dr. Natelson Love of the University of Alabama at Birmingham has no relevant financial relationships to disclose. ) Victor W Mark MD, editor. ( Dr.
More informationNIH Public Access Author Manuscript Semin Neurol. Author manuscript; available in PMC 2014 November 14.
NIH Public Access Author Manuscript Published in final edited form as: Semin Neurol. 2013 September ; 33(4): 386 416. doi:10.1055/s-0033-1359312. Neuroimaging Biomarkers of Neurodegenerative Diseases and
More informationDementia and Aphasia-AD, FTD & aphasia
特別講演 Dementia and Aphasia-AD, FTD & aphasia Shunichiro Shinagawa, Bruce L. Miller Key words : Alzheimer s disease, frontotemporal dementia, primary progressive aphasia Alzheimer s disease(ad)and frontotemporal
More informationContents. Introduction. Introduction 03
Genes and dementia Introduction This information is for anyone who wants to know more about the link between genes and dementia. This includes people living with dementia, their carers, friends and families.
More informationWhat if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia
What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia Dementia: broad term for any acquired brain condition impairing mental function such that ADLs are impaired. Includes:
More informationKey emerging issues in frontotemporal dementia
Key emerging issues in frontotemporal dementia Sarah Hopkins 1, Dennis Chan 2 1 Department of Medicine for the Elderly, Addenbrooke s Hospital, Cambridge 2 Department of Clinical Neurosciences, University
More informationWhat is primary progressive aphasia?
What is primary progressive aphasia? Introduction This leaflet is about primary progressive aphasia (PPA), a rare form of dementia. It s for anyone who may be worried about themselves or somebody else.
More informationEarly Onset Dementia From the background to the foreground
Early Onset Dementia From the background to the foreground Dr Jeremy Isaacs Consultant Neurologist St George s Hospital Excellence in specialist and community healthcare Themes of my talk The early onset
More informationOutline. Clinicopathologic Conference RAIN Case Presentation. Case Presentation. Pathology Presentation. Closing Remarks
Outline Clinicopathologic Conference RAIN 2017 Case Presenter: Scott Caganap, MD Clinical Discussant: Gil Rabinovici, MD Pathology Discussant: Lea Grinberg, MD, PhD Case Presentation 1. History and Exam
More informationClinical phenotypes in autopsy-confirmed Pick disease
Clinical phenotypes in autopsy-confirmed Pick disease O. Piguet, PhD G.M. Halliday, PhD W.G.J. Reid, PhD B. Casey, PhD R. Carman, MPhil Y. Huang, PhD J.H. Xuereb, MD J.R. Hodges, FRCP J.J. Kril, PhD Address
More informationDEFINING THE NEUROPSYCHOLOGICAL AND NEUROIMAGING PHENOTYPE OF BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA SUBMITTED TO UNIVERSITY COLLEGE LONDON
DEFINING THE NEUROPSYCHOLOGICAL AND NEUROIMAGING PHENOTYPE OF BEHAVIOURAL VARIANT FRONTOTEMPORAL DEMENTIA SUBMITTED TO UNIVERSITY COLLEGE LONDON FOR THE DEGREE OF DOCTOR OF PHILOSOPHY LAURA EMILY DOWNEY
More informationDISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT
Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease
More informationNon Alzheimer Dementias
Non Alzheimer Dementias Randolph B Schiffer Department of Neuropsychiatry and Behavioral Science Texas Tech University Health Sciences Center 9/11/2007 Statement of Financial Disclosure Randolph B Schiffer,,
More informationFor carers and relatives of people with frontotemporal dementia and semantic dementia. Newsletter
For carers and relatives of people with frontotemporal dementia and semantic dementia Newsletter AUGUST 2008 1 Welcome Welcome to the August edition of our CFU Support Group Newsletter. Thanks to all of
More informationBehavioural variant frontotemporal dementia with dominant gait disturbances case report
Psychiatr. Pol. 2016; 50(2): 329 336 PL ISSN 0033-2674 (PRINT), ISSN 2391-5854 (ONLINE) www.psychiatriapolska.pl DOI: http://dx.doi.org/10.12740/pp/58937 Behavioural variant frontotemporal dementia with
More informationBrain Advance Access published February 25, doi: /brain/awu024 Brain 2014: Page 1 of 17 1
Brain Advance Access published February 25, 2014 doi:10.1093/brain/awu024 Brain 2014: Page 1 of 17 1 BRAIN A JOURNAL OF NEUROLOGY Asymmetry and heterogeneity of Alzheimer s and frontotemporal pathology
More informationFrontotemporal Dementia and Related Disorders: Deciphering the Enigma
NEUROLOGICAL PROGRESS Frontotemporal Dementia and Related Disorders: Deciphering the Enigma Keith A. Josephs, MST, MD In the past century, particularly the last decade, there has been enormous progress
More informationClinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA
Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal
More informationDementia: A Comprehensive Update Neuroimaging, CSF, and genetic biomarkers in dementia
Dementia: A Comprehensive Update 2016 Neuroimaging, CSF, and genetic biomarkers in dementia Bradford C. Dickerson, M.D. Associate Professor of Neurology, Harvard Medical School Departments of Neurology
More informationTHIRUVANANTHAPURAM, KERALA
SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY THIRUVANANTHAPURAM, KERALA Demographic, clinical and syndromic characteristics of Frontotemporal dementia: A descriptive study. Thesis
More informationVersion 3.0, March 2015
NACC UNIFORM data set FTLD MODULE Coding Guidebook for FVP Version 3.0, March 2015 Copyright 2013, 2015 University of Washington. Created and published by the FTLD work group of the ADC Program (David
More informationPresenter Disclosure Information. I have no financial relationships to disclose:
Sandra Weintraub, Ph.D. Cognitive Neurology and Alzheimer s Disease Center Northwestern University, Feinberg School of Medicine Chicago, Illinois http://www.brain.northwestern.edu/dementia/ppa/index.html
More informationLEARN ABOUT: Frontotemporal dementia Primary progressive aphasia Movement disorders
LEARN ABOUT: Frontotemporal dementia Primary progressive aphasia Movement disorders National Institute on Aging National Institute of Neurological Disorders and Stroke The National Institute on Aging (NIA)
More informationClinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort
doi:10.1093/brain/awv358 BRAIN 2016: 139; 452 467 452 Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort Sara Van Mossevelde, 1,2,3,4 Julie van
More informationThe Frontotemporal Dementias: what we find and what we do. Chiadi U. Onyike, MD, MHS Johns Hopkins Neuropsychiatry
The Frontotemporal Dementias: what we find and what we do Chiadi U. Onyike, MD, MHS Johns Hopkins Neuropsychiatry Fair balance No financial or intellectual conflicts Pharmacologic interventions discussed
More informationFrontal Behavioural Inventory (FBI)
This is a Sample version of the Frontal Behavioural Inventory (FBI) The full version of the Frontal Behavioural Inventory (FBI) comes without sample watermark. The full complete version includes Complete
More informationDiagnosing Dementia: Signs & symptoms, differential diagnosis of common dementias, and non-degenerative memory loss
Diagnosing Dementia: Signs & symptoms, differential diagnosis of common dementias, and non-degenerative memory loss Incidence of Common Neurological Diseases Incidence New Cases Disease (per 100,000) (per
More informationDEMENTIA ANDREA BERG, MD
DEMENTIA ANDREA BERG, MD What Is Dementia? Decline in memory, language, problem-solving and other cognitive skills that affects a persons ability to perform everyday activities Progressive and disabling
More informationDiagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16
The impact of FDG PET in degenerative dementia diagnosis Jung Lung, Hsu MD, Ph.D (Utrecht) Section of dementia and cognitive impairment Department of Neurology Chang Gung Memorial Hospital, Linkou, Taipei
More informationA Healthcare Provider s Guide To Behavioral Variant Frontotemporal Dementia (bvftd):
A Healthcare Provider s Guide To Behavioral Variant Frontotemporal Dementia (bvftd): Diagnosis, pharmacologic management, non-pharmacologic management, and other considerations This material is provided
More informationDementia. Amber Eker, MD. Assistant Professor Near East University Department of Neurology
Dementia Amber Eker, MD Assistant Professor Near East University Department of Neurology Dementia An acquired syndrome consisting of a decline in memory and other cognitive functions Impairment in social
More informationClinical Diagnosis. Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV)
Step 1: Dementia or not? Diagnostic criteria for dementia (DSM-IV) A. The development of multiple cognitive deficits manifested by both 1 and 2 1 1. Memory impairment 2. One (or more) of the following
More informationFTD Genetics: for patients and families. Kirk Wilhelmsen, M.D., Ph.D UNC
FTD Genetics: for patients and families Kirk Wilhelmsen, M.D., Ph.D UNC UNC The Human Genome 22 Pairs of Chromosomes 2 Sex Chromosomes 3,300,000,000 basepairs of DN 7-14 picograms of DN per cell ~20,000
More informationLEARN ABOUT: Frontotemporal dementia Primary progressive aphasia Movement disorders. National Institute on Aging National Institutes of Health
LEARN ABOUT: Frontotemporal dementia Primary progressive aphasia Movement disorders National Institute on Aging National Institutes of Health The National Institute on Aging (NIA), part of the National
More informationdoi: /brain/awr361 Brain 2012: 135;
doi:10.1093/brain/awr361 Brain 2012: 135; 736 750 736 BRAIN A JOURNAL OF NEUROLOGY Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological
More informationBiomarkers to Identify the Pathological Basis for Frontotemporal Lobar Degeneration
J Mol Neurosci (2011) 45:366 371 DOI 10.1007/s12031-011-9597-0 Biomarkers to Identify the Pathological Basis for Frontotemporal Lobar Degeneration Murray Grossman Received: 6 June 2011 /Accepted: 11 July
More informationDifferential Diagnosis
Differential Diagnosis 2 2.1 Introduction AD accounts for up to 75 % of all dementia cases. The differential diagnosis with other conditions is sometimes challenging since several disorders may produce
More informationScreening for Cognitive Dysfunction in Corticobasal Syndrome: Utility of Addenbrooke s Cognitive Examination
Original Research Article DOI: 10.1159/000327169 Accepted: March 8, 2011 Published online: April 8, 2011 Screening for Cognitive Dysfunction in Corticobasal Syndrome: Utility of Addenbrooke s Cognitive
More informationFRONTOTEMPORAL LOBAR DEgeneration
ORIGINAL CONTRIBUTION Parietal Lobe Deficits in Frontotemporal Lobar Degeneration Caused by a Mutation in the Progranulin Gene Jonathan D. Rohrer, MRCP; Jason D. Warren, PhD, FRACP; Rohani Omar, MRCP;
More informationALS, Cognitive Impairment (CI) and Frontotemporal Lobar Dementia (FTLD): A Professional s Guide
ALS, Cognitive Impairment (CI) and Frontotemporal Lobar Dementia (FTLD): A Professional s Guide Overview A link between ALS and cognitive dysfunction was first noted in the late 1800 s, but only in the
More informationCurrent Concepts in the Classification and Diagnosis of Frontotemporal Lobar Degenerations
Current Concepts in the Classification and Diagnosis of Frontotemporal Lobar Degenerations Frontotemporal lobar degenerations are clinically, genetically, and molecularly heterogeneous diseases characterized
More informationCONSENSUS PAPER. Acta Neuropathol (2007) 114:5 22 DOI /s
Acta Neuropathol (2007) 114:5 22 DOI 10.1007/s00401-007-0237-2 CONSENSUS PAPER Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal
More informationClinicopathological and imaging correlates of progressive aphasia and apraxia of speech
doi:10.1093/brain/awl078 Brain (2006), 129, 1385 1398 Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech Keith A. Josephs, 1,2 Joseph R. Duffy, 3 Edyth A. Strand, 3
More informationNeuro degenerative PET image from FDG, amyloid to Tau
Neuro degenerative PET image from FDG, amyloid to Tau Kun Ju Lin ( ) MD, Ph.D Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital ( ) Department of Medical Imaging
More informationCNADC. S. Weintraub, CNADC, Northwestern FSM, 2011 DO NOT COPY OR DISTRIBUTE WITHOUT AUTHORʼS PERMISSION
Sandra Weintraub, Ph.D. Clinical Core Director, Cognitive Neurology and Alzheimer s Disease Center Northwestern University Feinberg School of Medicine Changing concepts of cognitive aging Neurodegenerative
More informationFrontotemporal Dementia (FTD) Take home points. FTD Prevalence. Frontotemporal dementia: clinical syndromes and pathobiology
Frontotemporal Dementia (FTD) Frontotemporal dementia: clinical syndromes and pathobiology William W. Seeley, MD Associate Professor of Neurology and Pathology UCSF Recent Advances in Neurology February
More information02/04/2015. The structure of the talk. Dementia as a motor disorder. Movement, cognition & behaviour. Example 1. Example 2
The th Annual Memory Clinic Conference Dublin, Trinity College, 27 March 1 The structure of the talk Dementia as a motor disorder Thomas H. Bak Human Cognitive Neuroscience & Centre for Clinical Brain
More informationAging often includes changes to vision, hearing, taste, smell, skin, hair, weight & changes to Brain:
Aging & Cognition Ladan Ghazi Saidi, Ph.D., Assistant Professor, Department of Communication Disorders, COE, University of Nebraska at Kearney 2018 Nebraska Speech-Language-Hearing Association Fall Convention
More informationDementia. Stephen S. Flitman, MD Medical Director 21st Century Neurology
Dementia Stephen S. Flitman, MD Medical Director 21st Century Neurology www.neurozone.org Dementia is a syndrome Progressive memory loss, plus Progressive loss of one or more cognitive functions: Language
More informationNeuroimaging Biomarkers of Neurodegenerative Diseases and Dementia
386 Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia Shannon L. Risacher, PhD 1 Andrew J. Saykin, PsyD 1 1 Center for Neuroimaging, Department of Radiology and Imaging Sciences, and Indiana
More informationDifferential Diagnosis of Hypokinetic Movement Disorders
Differential Diagnosis of Hypokinetic Movement Disorders Dr Donald Grosset Consultant Neurologist - Honorary Professor Institute of Neurological Sciences - Glasgow University Hypokinetic Parkinson's Disease
More information